Comparative Effectiveness and Safety of Oral Anticoagulants across Kidney Function in Patients with Atrial Fibrillation

BACKGROUND: Patients with atrial fibrillation (AF) and severely decreased kidney function were excluded from the pivotal NOAC trials, thereby raising questions about comparative safety and effectiveness in patients with reduced kidney function. The study aimed to compare oral anticoagulants across t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Cardiovasc Qual Outcomes
Main Authors: Yao, Xiaoxi, Inselman, Jonathan W., Ross, Joseph S., Izem, Rima, Graham, David J., Martin, David B., Thompson, Aliza M., Southworth, Mary Ross, Siontis, Konstantinos C., Ngufor, Che G., Nath, Karl A., Desai, Nihar R., Nallamothu, Brahmajee K., Saran, Rajiv, Shah, Nilay D., Noseworthy, Peter A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7580213/
https://ncbi.nlm.nih.gov/pubmed/33012172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.120.006515
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados